{"id":69014,"date":"2023-07-28T11:46:56","date_gmt":"2023-07-28T11:46:56","guid":{"rendered":"https:\/\/www.pharmacie-vezere.com\/promotions\/?p=69014"},"modified":"2023-07-28T11:52:06","modified_gmt":"2023-07-28T11:52:06","slug":"resultats-dune-nouvelle-etude-sur-le-traitement-de-la-migraine-et-de-la-depression","status":"publish","type":"post","link":"https:\/\/www.pharmacie-vezere.com\/promotions\/resultats-dune-nouvelle-etude-sur-le-traitement-de-la-migraine-et-de-la-depression\/","title":{"rendered":"R\u00e9sultats d&#8217;une nouvelle \u00e9tude sur le traitement de la migraine et de la d\u00e9pression"},"content":{"rendered":"\n<p>L&#8217;\u00e9tude r\u00e9cente UNITE r\u00e9alis\u00e9e par des chercheurs de l&#8217;Universit\u00e9 de Pittsburgh et de l&#8217;UPMC a d\u00e9voil\u00e9 des r\u00e9sultats prometteurs concernant le traitement des patients souffrant \u00e0 la fois de migraines et de troubles d\u00e9pressifs majeurs. L&#8217;\u00e9tude s&#8217;est concentr\u00e9e sur l&#8217;utilisation du fremanezumab, un anticorps monoclonal enti\u00e8rement humanis\u00e9 qui cible le peptide li\u00e9 au g\u00e8ne de la calcitonine (CGRP). Les r\u00e9sultats, pr\u00e9sent\u00e9s lors de la conf\u00e9rence de l&#8217;American Headache Society (AHS) en juin 2023, ont d\u00e9montr\u00e9 que l&#8217;administration de fremanezumab a entra\u00een\u00e9 une r\u00e9duction significative de la gravit\u00e9 des sympt\u00f4mes d\u00e9pressifs chez ces patients.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-content\/uploads\/2023\/07\/2023-07-28T144919.535.jpg\" alt=\"\" class=\"wp-image-69015\" width=\"659\" height=\"496\" srcset=\"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-content\/uploads\/2023\/07\/2023-07-28T144919.535.jpg 259w, https:\/\/www.pharmacie-vezere.com\/promotions\/wp-content\/uploads\/2023\/07\/2023-07-28T144919.535-200x151.jpg 200w\" sizes=\"auto, (max-width: 659px) 100vw, 659px\" \/><\/figure>\n\n\n\n<p>La migraine et la d\u00e9pression sont des affections difficiles \u00e0 traiter, et les patients \u00e9prouvent souvent des sympt\u00f4mes chevauchants, ce qui r\u00e9duit leur qualit\u00e9 de vie et augmente leur invalidit\u00e9. Des recherches ant\u00e9rieures avaient soulign\u00e9 la n\u00e9cessit\u00e9 de recommandations cliniques fond\u00e9es sur des preuves et de meilleures approches de traitement. L&#8217;\u00e9tude UNITE visait \u00e0 r\u00e9pondre \u00e0 cette probl\u00e9matique en \u00e9valuant l&#8217;efficacit\u00e9 du fremanezumab chez les patients atteints \u00e0 la fois de migraines et de troubles d\u00e9pressifs majeurs.<\/p>\n\n\n\n<p>L&#8217;\u00e9tude a inclus 330 participants adultes pr\u00e9sentant des sympt\u00f4mes de troubles d\u00e9pressifs majeurs et de migraines mod\u00e9r\u00e9es \u00e0 s\u00e9v\u00e8res. Les participants ont \u00e9t\u00e9 r\u00e9partis au hasard en deux groupes, l&#8217;un recevant une injection sous-cutan\u00e9e mensuelle de 225 mg de fremanezumab et l&#8217;autre un placebo. La p\u00e9riode de traitement a dur\u00e9 12 semaines, suivie d&#8217;une phase ouverte de 12 semaines suppl\u00e9mentaires.<\/p>\n\n\n\n<p>Les r\u00e9sultats \u00e9taient tr\u00e8s encourageants, indiquant que les patients trait\u00e9s avec du fremanezumab ont connu une r\u00e9duction statistiquement significative de la gravit\u00e9 de la d\u00e9pression, mesur\u00e9e par l&#8217;\u00e9chelle de d\u00e9pression de Hamilton \u00e0 17 items (HAMD-17) et le questionnaire de sant\u00e9 du patient \u00e0 9 items (PHQ-9), par rapport au groupe placebo. Les effets b\u00e9n\u00e9fiques ont \u00e9t\u00e9 observ\u00e9s d\u00e8s la 8e semaine et se sont maintenus tout au long de la p\u00e9riode de suivi de 12 semaines.<\/p>\n\n\n\n<p>Le chercheur principal de l&#8217;\u00e9tude, Richard B. Lipton, a soulign\u00e9 l&#8217;importance de ces r\u00e9sultats. Il a mis en \u00e9vidence que le fremanezumab r\u00e9duisait efficacement les sympt\u00f4mes \u00e0 la fois de la migraine et de la d\u00e9pression, tout en pr\u00e9sentant un avantage par rapport \u00e0 d&#8217;autres traitements susceptibles d&#8217;atteindre le cerveau et de provoquer des effets secondaires. Cette caract\u00e9ristique fait du fremanezumab une option attrayante pour les patients souffrant des deux affections.<\/p>\n\n\n\n<p>Ces r\u00e9sultats fournissent des informations pr\u00e9cieuses sur les avantages potentiels du fremanezumab dans le traitement de la migraine et des troubles d\u00e9pressifs majeurs comorbides. \u00c0 mesure que de nouvelles recherches seront men\u00e9es, la communaut\u00e9 m\u00e9dicale pourra mieux comprendre les effets \u00e0 long terme du m\u00e9dicament et son r\u00f4le dans l&#8217;am\u00e9lioration de la vie des patients confront\u00e9s \u00e0 ces affections difficiles.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;\u00e9tude r\u00e9cente UNITE r\u00e9alis\u00e9e par des chercheurs de l&#8217;Universit\u00e9 de Pittsburgh et de l&#8217;UPMC a d\u00e9voil\u00e9 des r\u00e9sultats prometteurs concernant le traitement des patients souffrant \u00e0 la fois de migraines et de troubles d\u00e9pressifs majeurs. L&#8217;\u00e9tude s&#8217;est concentr\u00e9e sur l&#8217;utilisation du fremanezumab, un anticorps monoclonal enti\u00e8rement humanis\u00e9 qui cible le peptide li\u00e9 au g\u00e8ne de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":69016,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[684],"tags":[],"class_list":["post-69014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelles-pharmaceutiques"],"_links":{"self":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/comments?post=69014"}],"version-history":[{"count":1,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69014\/revisions"}],"predecessor-version":[{"id":69017,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69014\/revisions\/69017"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/media\/69016"}],"wp:attachment":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/media?parent=69014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/categories?post=69014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/tags?post=69014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}